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Abstract
Background: To determine the impacts of visual impairment and eye diseases on vision-related quality of life (QoL) in
populations with severe visual impairment (SVI) and blindness in Indonesia. Methods: A cross-sectional study was
conducted on 134 respondents from, 5 different provinces, simultaneously with a validation study using data from the
2013 National Basic Health Survey. Participants aged ≥18 years with visual acuity of <6/60 underwent an ocular
examination and guided interview. The impact of vision impairment related to their QoL was assessed using the NEIVFQ 25 questionnaire. The scores were then compared between participants with blindness (<3/60) and participants
with SVI (> 3/60 to < 5/60), and the causes of visual impairment. Results: Severe visual impairment and blindness were
mostly found in productive aged females with lower education and income levels, and cataracts were the leading cause.
Vision-related quality of life was lower in the blind group compared to the SVI group (p = 0.001). The impacts of visual
impairment related mostly to distance activities (p = 0.007), social functions, and near activities (p = 0.002). NEI-VFQ
25 scores were lower in glaucoma respondents than cataract respondents. Conclusions: Results suggest that subjects
with blindness had a lower total QoL score than those with SVI, in addition to the subscale scores. Furthermore,
glaucoma disease had the lowest QoL score.
Keywords: impact vision, quality of life, NEI-VFQ 25, severe visual impairment, blindness, ocular morbidity

of people with impaired vision, based on their type of
diseases, are essential particularly for appropriate input
on policies regarding prevention of blindness.16-20
Numerous studies in various countries have
demonstrated that the NEI-VFQ 25 questionnaire is a
valid instrument in assessing vision-related quality of
life.10-12,16,18 By using this questionnaire in the present
research, it is expected that the results of this study can
be compared to other research that has used the same
tools. Additionally, the questionnaire has specific
instructions on how to answer the questions, thus all the
answers can be standardised.12,21

Introduction
According to the WHO, it is estimated that the number
of people with visual impairment worldwide is 285
million, and the majority of those (87%) live in
developing countries.1 According to the National Eye
Health Survey carried out between 1993 and 1996,
blindness in Indonesia had reached 1.5% of the total
population, with the leading causes of blindness being
cataracts, glaucoma, and uncorrected refractive errors.2
Visual impairment and blindness may result in
decreased quality of life (QoL), which is associated with
a reduction in one's ability to work, to spend leisure
time, or perform daily activities. Additionally, they
experience a higher risk of falls, fractures of the femur,
and medication errors.3-9

The Indonesian National Basic Health Research
(INBHR) has conducted epidemiological studies on
multiple health issues in several areas of Indonesia,
including eye morbidity and blindness.22 Their 2013
study suggested that cases of blindness have decreased
to 0.9% of the total population in Indonesia, however
their methodology differed to the standard survey
recommended by the WHO. As such, data relating to
blindness and eye morbidity from the 2013 INBHR
needs to be validated. This present study was one of
several validation studies conducted by the Indonesian
Ophthalmologist Association. It aims to determine the

The formal examination of visual acuity and visual
fields may not be the most objective way of testing
patients, as it does not accurately show the overall
impacts of vision-related disorders experienced by the
patient.
Subjective
assessments
(self-reported
evaluations) on quality of life, using a questionnaire, are
necessary to provide a more comprehensive eye health
assessment.10-15 Further studies demonstrating the QoL
104
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impacts of visual impairment and ocular morbidity on
vision-related QoL within the Indonesian population
who experience SVI and blindness and compare the
findings with those reported by the INBHR .

Methods
Population. This present study was conducted
simultaneously with the Blindness Validation Study
performed by the Indonesian Ophthalmologists
Association, in order to evaluate the validity of the
INBHR study. This was a cross-sectional population
based study that was performed by the investigator and
other residents, who had received training on how to
correctly fill in the questionnaire. Ethical approval from
the Ethics Committee of the Ministry of Health
(LB.02.01/5.2/KE.402/2013) was obtained, as suggested
by the Helsinki Declaration. The 2013 INBHR study
showed that there was 1154 subjects categorised as
blind and 2259 with SVI in 8 provinces across Indonesia.
The validation team selected 3 districts from 5 provinces
that had a higher proportion of visual impairment and
blind patients to be included in the study. All subjects
who had been diagnosed with SVI or blindness in the
INBHR study were visited door to door or invited to the
Primary Health Care Unit. They underwent eye evaluations, including a visual acuity test (Snellen chart),
measurement of intraocular pressure (applanation
tonometry), assessment of the eye using a slit-lamp, and
evaluation of the fundus retina. There were a total of
145 subjects diagnosed with SVI or blindness by the
validation team that met our inclusion criteria. Purposive
sampling was carried out for the inclusion and exclusion
criteria amongst the 145 subjects, and they were
categorised with either SVI or blind by the validation
team. All respondents aged 18 years and older with SVI
(≥ 3/60 to < 6/60 in their better eye) were placed into
Group 1, and those with blindness (< 3/60 in their better
eye) were placed into Group 2 and were included in the
study. All respondents signed an informed consent form
prior to participation in the study.
Instruments for QoL Questionnaire. After the
respondents completed an ophthalmologic examination,
which was performed to determine the cause of visual
impairment, they were interviewed using questionnaires
by trained interviewers. The modified and translated
National Eye Institute Visual Function Questionnaire 25
(NEI-VFQ 25) was used to assess the vision related
QoL among all respondents, and this questionnaire had
been validated beforehand. The Medical Education
Program at the Faculty of Medicine conducted the
validation of the questionnaire. A staff member of the
Department of Medical Education carried out the
assessment of sig-nificant similarities between the
original and translated questionnaires. The format of the
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questionnaire was also modified slightly to make it
easier for the interviewer to fill in responses.
Demographic information including age, gender,
education, household income, marital status, cause of
blindness, and systemic health diseases were noted. The
modified NEI-VFQ 25 contained a total of 25 questions,
which was divided into 3 groups. Part 1 was a general
health and visual health ques-tionnaire. Part 2 related to
the difficulty experienced in doing daily activities,
social functions, and mental health, and part 3 was
mostly related to responses regarding vision problems.
Each question had a range of 0 to 100, with 100 being
the highest score and 0 being the lowest score. Each
question in part 2 and 3 consisted of subscale questions,
and the average number of scores was taken. The
composite of all the scores was the total number of
visual functionality. The total and subscale QoL scores
were compared between groups, and the causes of eye
disease and blindness onset were also evaluated.
Interviewers in different locations were briefed on how
to conduct the interviews in order to have similar
perceptions of the questionnaire. As different locations
have their own language dialects, interviewers were
allowed to communicate in the local dialects so that the
respondents of the study were able to understand the
questions clearly.
Statistic analysis. The statistical analysis was
performed using SPSS version 16.0, with 2 tail p < 0.05
considered significant. The minimum sample size for
each group was 50 respondents, which was calculated
using the formula of mean values for unpaired twosample t-test. Numerical data was presented as mean
and standard deviations for data with normal
distribution, and as median, minimum, and maximum
values for data without normal distribution. The
descriptive analysis of variables used was t-tests for
quantitative and χ2 tests for categorical variables to
compare different groups.

Results
Demographic Characteristics. A total of 145 respondents
were included in the study, however 11 respondents
were excluded due to hearing loss and attention deficit
disorder. The remaining 134 respondents were analysed.
There were 88 subjects diagnosed with blindness
(65.7%) and 46 subjects with SVI (34.3%), as outlined
in Table 1. There were more female (64.2%) than male
(35.8%) subjects in the study. The mean age was 67.4
(± 12.3) years and 46 respondents (34.3%) were at their
productive age. Most respondents had low educational
levels (65.7%) and low incomes (71.6%), and 26.7% of
them had experienced blindness for more than 5 years.
The mean duration of visual impairment was 6.4 (±10.3)
years (0.08 to 50 years).
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Table 1. Demographic Characteristics of Subjects, Duration, and Cause of Eye Diseases based on Level of Visual
impairment (n = 134)

Variables

Total Respondents
(N = 134)
n
%

Blindness
(N = 88)
n

SVI
(N = 46)
%

n

p
%

Sex
Male
Female
Mean age (years)

48
35.8
86
64.2
67.4 ± 12.3

28
31.8
60
68.2
69.5 (38-95)

20
3.5
26
6.5
67.5 (28-92)

Age Group
18-64 years
> 64 years

46
88

34.3
65.7

34
54

38.6
61.4

12
34

26.1
73.9

0.232a

Level of Education
Low
Medium
High

88
43
3

65.7
32.1
2.2

60
26
2

68.2
29.5
2.3

28
17
1

60.9
36.9
2.2

0.392a

96
20
10
8

71.6
14.9
7.5
6

60
15
8
5

68.2
17
9.1
5.7

36
5
2
3

78.3
10.9
4.3
6.5

0.462a

Income Level
Low
Medium
High
Very High
Duration of visual impairment
(years)

6.4 ± 10

0.173b

2 (0.08 to 30)

3 (0.08 to 54)

0.104b
0.104b

Duration of blindness
< 1 year
1-5 years
> 5 years

37
59
35

28.2
45.1
26.7

21
41
25

24.1
47.1
28.8

6
8
0

36.4
40.9
22.7

Types of eye disease
Cataracts
Glaucoma
Refractive errors
Corneal abnormalities
AMD
Optic neuropathy
Diabetic retinopathy
Retinal detachments
Other eye disorders

99
7
9
5
2
7
1
2
2

73.9
5.2
6.7
3.7
1.5
5.2
0.7
1.5
1.5

63
6
4
5
2
4
0
2
2

71.6
6.8
4.5
5.7
2.3
4.5
0
2.3
2.3

36
1
5
0
0
3
1
0
0

78.3
2.2
10.9
0
0
6.5
2.2
0
0

aChi-square

0.181a

test ; bMann-Whitney test

Cataract was the major leading cause of visual
impairment (73.9%), which was followed by refractive
errors (6.7%), and glaucoma (5.2%). Statistical tests of
multiple variables on demographic characteristics and
duration of vision impairment showed that the
distribution of the samples were homogeneous (p >
0.05). The Impact of Visual Impairment on their Quality
of Life. The mean total score of QoL (composite score)
of all respondents was 41.97 (±19.66), as presented in
Table 2. Male respondents had a better mean total score
of QoL than women, however the score between both
groups was not significantly significant (p = 0.280).
Quality of Life in the productive age respondents was
higher than those in the non-productive age group (p =
Makara J. Health Res.

0.007). The duration of visual impairment was not
associated with QoL score.
The Impact on Subjects with Blindness and Severe Visual
Impairment in QoL. The mean total score of QoL in the
blind group was lower than those with SVI (p = 0.001),
however the average QoL subscale scores for both
groups were varied. Subjects with blindness were more
likely to have lower subscale QoL scores than those
with SVI, especially in social functions (p = 0.001),
difficulty in maintaining their job role (p = 0.008), near
activities (p = 0.000), and distance activities (p = 0.000).
There were no significant differences in general health
subscale scores (p = 0.740), eye pain (p = 0.098), mental
December 2017 | Vol. 21 | No. 3
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health (p = 0.210), and dependency (p = 0.080) between
both groups, as outlined in Table 3.
The Impact of QoL Scores Amongst Subjects with
Various Eye Diseases. As presented in Table 4,
respondents with glaucoma had the lowest total QoL
score than subjects with any other disease. Since the
sample size for each aetiology varied widely, the
statistical comparisons were performed among only
three groups of diseases, glaucoma, cataracts, and
refractive errors. Respondents with glaucoma had the
lowest QoL scores, especially in dependency parameters.
Moreover, regarding almost all the subscale scores,
except for the score on difficulty in maintaining job
role, our study showed that respondents with glaucoma
had a lower score than those with cataracts.
The number of female respondents with SVI and
blindness was higher than the male subjects, 2 out of 3
respondents, results that are again consistent with a
WHO report and various other studies.23 However, the
total scores between the male and female subjects were
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relatively similar and the difference was not statistically
significant. We found that 25% of respondents with
blindness were in their productive age. The total QoL
score in subjects in the productive age group was higher
than those in the non-productive age group. The higher
score was likely due to comorbidities and the aging
process that can affect quality of life in subjects of the
non-productive age group. Most respondents had a
lower level of education that was closely associated with
illiteracy and low income. Endeavours that promote
education regarding eye health and prevention of
disease are necessary and should be adjusted with the
education level of the respondents.
The majority of respondents in the present study had
experienced blindness for the past 1 to 5 years. Nispen
et al.20 suggested that reduced quality of life is affected
by comorbidities, however other authors have not confirmed the suggestion.8 The longer a person experiences
blindness their quality of life tends to improve, this is
likely caused by the adaptation mechanism (coping
index).24-27

Table 2. Total QoL Scores based on Gender, Age Group, and Duration of Blindness
Variables
The mean total score (N)
Gender
Male
Female
Age group (year)
18-64 years
> 64 years
Duration of blindness
< 1 year
1-5 years
> 5 years

Average (mean ± SD)
41.9 ± 19.6

Median (min-max)
39.82 (2.5-89.4)

p

43.4 ± 16.7
41.2 ± 21.2

42.1 (15-84.6)
39.2 (2.5-89.4)

0.280 A

48.5 ± 20.5
38.5 ± 18.4

45.7 (10.4-89.4)
33.7 (2.5-86.8)

0.007 a

43.3 ± 18.4
40.6 ± 20.3
42.9 ± 18.9

39.0 (17.5-83.7)
39.8 (2.5-86.8)
40.5 (10.4-89.4)

0.710 b

a = Mann-Whitney test; b = Kruskal-Wallis test

Table 3. Total and Subscale Scores of QoL based on Level of Visual Impairment
Variable Scores
Total score
General health
Eye Health
Eye pain
Near activity
Distance activity
Social function
Mental Health
Difficulty in
maintaining role
Dependency
Colour vision
Peripheral vision

Severe visual impairment
(n = 46)
Mean ± SD
Median
49.8 ± 19.20
49.7 (16.5-89.4)
36.1 ± 22.30
25.0 (0-100)
33.8 ± 13.40
40.0 (20-60)
68.5 ± 21.60
62.5 (25-100)
46.7 ± 30.40
50.0 (0-100)

Blindness
(n = 88)
Mean ± SD
37.8 + 18.80
36.0 ± 21.90
24.4 ± 15.80
74.7 ± 23.70
26.2 ± 24.50

Median
33.5 (2.5-85.7)
25.0 (0-100)
20.0 (0-60)
75.0 (0-100)
25.0 (0-100)

0.001
0.740
0.003
0.098
0.000

46.6 ± 26.60
52.7 ± 28.80
53.6 ± 21.50
44.4 ± 24.06

50.0 (0-100)
50.0 (0-100)
50 (12.5 to 100)
37.5 (0-100)

25.9 ± 25.50
33.2 ± 28.00
48.7 ± 21.40
35.7 ± 25.20

20.8 (0-100)
25.0 (0-100)
50 (0-100)
25.0 (0-100)

0.000
0.001
0.210*
0.009

49.2 ± 26.70
62.2 ± 32.20
50.5 ± 31.70

50.0 (0-100)
50.0 (0-100)
50.0 (0-100)

36.5 ± 26.70
42.7 ± 34.90
28.5 ± 28.70

33.3 (0-100)
37.5 (0-100)
25.0 (0-100)

0.080
0.002
0.000

p

* = Independent T-test;
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Table 4. Comparison of the Total and Subscale Scores of QoL in Several Diseases (n = 134)

Variable Scores
Total score
General health
Eye Health
Eye pain
Near activity
Distance activity
Social function
Mental Health
Difficulty in
maintaining role
Dependence
Colour vision
Peripheral vision

Abnormalities
refraction
(N = 9)
62.4 ± 19.8
50
(25-100)
40
(20-60)

Retinal
abnormalities
(N = 5)
52.3 ± 24.8

Optic
neuropathy
(N = 7)
45.0 ± 16.2
50
(0-50)
20
(20-40)

Corneal
abnormalities
(N = 5)
49.0 ± 19.6

74.8 ± 17.8

71.3 ± 25

72.5 ± 20

76.8 ± 16.8

74.9 ± 23.5

20.7 ± 18.2

57.8 ± 29.4

41.6 ± 27.6

28.5 ± 19.8

54.9 ± 28

8.3
(8-58.3)

55.2 ± 32.4

48.3 ± 36.9

41.6 (0-50)

44.9 ± 30.4

32 ± 21.5

70.3 ± 24.0

55 ± 45

42.8 ± 27.8

44.9 ± 36

40.2 ± 9.4

64.1 ± 27.5

60 ± 27.1

58.9 ± 11.3

56.25 ± 22.1

48.2 ± 36

43.75 ± 31.3

47.5 ± 22.3

42.8 ± 18.9

37.5 ± 37.5

23.8 ± 20.6

65.6 ± 30.7

56.6 ± 34.1

45.2 ± 25.4

38.3 ± 33.6

25
(0-100)

92.3
(50-100)

65
(0-100)

71.4 ± 22.5

70
(25-100)

10.7 ± 13.4

68.7 ± 29.1

45 ± 51

28.6 ± 22.5

50 ± 25

Cataract

Glaucoma

(N = 99)
40.5 ± 19.2
25
(0-75)
20
(0-60)
72
(25-100)
25
(0-100)
25
(0-100)
37
(0-100)
50
(0-100)
25
(0-100)
33.3
(0-100)
50
(0-100)
25
(0-100)

(N = 9)
33.1 ± 9.0
50
(25-100)
20 ± 16.3

The QoL scores in the blind group were lower than
those in the SVI group and the difference was
statistically significant. The differences were in terms of
the severity of the total scores and for almost all of the
subscale scores, except for the mental health aspect. It
appears that since there were significant differences in
visual acuity, which is essential in daily activities,
subjects with blindness experienced impairment in both
near and distance activities. Mental health including
anxiety, fear, and frustration was relatively similar
between both groups. Productivity was much more
disturbed in subjects with blindness compared to those
with SVI. It is assumed that psychosocial and spiritual
factors may also contribute to these findings, evidence
which is also supported by other studies.27,28
Respondents with glaucoma had the lowest QoL scores
than respondents with other eye diseases in all measured
parameters, including general vision, mental health,
near activity, and role difficulty. As a result, the
glaucoma subjects are more dependent on other persons.
This happens because the deficit that occurs in
glaucoma is a combination of central and peripheral
vision disorders, as shown in this study. Glaucoma is an
irreversible chronic disease that is not easily detected in
early cases and typically causes permanent
blindness.29,30 The impact on the individual, and the
lifetime risk of causing disability and dependency,
Makara J. Health Res.

60 ± 28.5
32 ± 30

25.0 ± 25.0
40
(0-40)

increased the burden on their family and community.
Early detection of avoidable blindness, including
glaucoma, is essential in high-risk groups, especially in
those over 40 years of age, with reduced corneal
thickness, of African descent, and with a family history
of glaucoma.31 Quality of life scores from respondents
with uncorrected refractive errors was the highest when
compared to subjects with other diseases, such as
cataracts and glaucoma. Blindness due to refractive
errors and cataracts are usually avoidable. Refractive
error can be treated with glasses or other low vision
aids, and this may be the reason for the reported better
quality of life. Moreover, cataracts, without other
abnormalities, can be managed via a surgical approach
and the quality of life will increase significantly. The
respondent will usually be productive again in a
relatively period of short time, if the procedure is
performed appropriately.
A limitation of our study is in regards to the
appropriateness of the validated NEI-VFG 25
questionnaire. The questionnaires were used by more
than one interviewer and took place in five provinces, to
reflect the QoL in Indonesian communities who are
visually impaired. Although training for interviewers
regarding the procedure of completing the questionnaire
was provided, there was still a potential bias due to the
use of local dialects due to a limited command of
December 2017 | Vol. 21 | No. 3
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Bahasa Indonesia. Furthermore, the sample size for the
groups of subjects who were blind and those with SVI
were not proportionally balanced.

Conclusions
Results suggest that subjects with blindness had a lower
total QoL score than those with SVI. Furthermore,
glaucoma disease had the lowest QoL score when
compared to other diseases.
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